Updated Jul 16, 2026
Jampa Raj has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

According to the SEC filing context provided, Jampa Raj is identified as Chief Technology Officer of Myriad Genetics Inc as of June 2, 2026. Public biographical information about Raj’s education, career history, or prior roles is not widely published in readily accessible sources. The CTO role at a genomics company typically involves leadership of technology strategy, product development, and R&D in areas such as genetic testing and data analytics, but specific background or achievements for Raj are not publicly documented in common references.
| Role | Chief Technology Officer |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | MYGN | MYRIAD GENETICS INC | A — Grant or award | 251.9K | $0.00 |
According to the SEC filing context provided, Jampa Raj is identified as Chief Technology Officer of Myriad Genetics Inc as of June 2, 2026. Public biographical information about Raj’s education, career history, or prior roles is not widely published in readily accessible sources. The CTO role at a genomics company typically involves leadership of technology strategy, product d…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jampa Raj profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.